Polyfunctional molecules play an important role in the chemotherapeutic treatment of disease. The field of organic synthesis resides in the vanguard of pharmaceutical science, delivering both the small molecules for screening against biological targets, and ultimately the efficient processes for drug synthesis on an industrial scale. A large fraction of drug candidate syntheses depends on the selective functionalization of unique reactive sites within molecules that contain many such sites. Thus, the risk of undesired side reactions is extreme. To date, the dominant strategy to handle this situation is the use of """"""""protective groups."""""""" Protective groups are inherently inefficient. They require a step for installation, an additional step for removal, and neither of these steps generally occurs in 100% yield, with no waste, nor loss of time. Furthermore, from a fundamental standpoint, protective groups bely a host of unsolved problems in organic synthesis. Protective groups mask one reactive site, while allowing chemistry to occur at another. The more direct challenge in synthetic organic chemistry would be to achieve the desired reactivity, in the face of competing reactivity, without the inefficient application of such a mask. The development of tools - i.e., catalysts - that would allow the selective functionalization of very similar sites within polyfunctional molecules would constitute a major step forward. While the goal is, in some circles, viewed as intractable, we have initiated a program that has documented a potentially new strategy. The implications for both de novo syntheses of complex molecules are significant. Moreover, the implications of the protective group-free modification of pharmaceutically proven, structurally complex natural products is also highly exciting. The amazing biological activity of natural products has guided generations of synthetic organic chemists. Yet, notoriously, many pharmaceutical companies are de-emphasizing natural products discovery and drug development efforts. A major reason is the structural complexity that prevents both efficient synthesis, and straightforward analog generation. By taking aim at the direct, efficient and protecting group-free manipulation of natural products, we endeavor to introduce new tools that may assist in their exploration in both academic and industrial laboratories, enabling efficient access to novel and otherwise inaccessible biologically active analogs. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM068649-07
Application #
7483582
Study Section
Special Emphasis Panel (ZRG1-BCMB-B (02))
Program Officer
Schwab, John M
Project Start
2003-08-01
Project End
2011-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
7
Fiscal Year
2008
Total Cost
$299,373
Indirect Cost
Name
Yale University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Wadzinski, Tyler J; Steinauer, Angela; Hie, Liana et al. (2018) Rapid phenolic O-glycosylation of small molecules and complex unprotected peptides in aqueous solvent. Nat Chem 10:644-652
Kwon, Yongseok; Chinn, Alex J; Kim, Byoungmoo et al. (2018) Divergent Control of Point and Axial Stereogenicity: Catalytic Enantioselective C-N Bond-Forming Cross-Coupling and Catalyst-Controlled Atroposelective Cyclodehydration. Angew Chem Int Ed Engl 57:6251-6255
Key, Hanna M; Miller, Scott J (2017) Site- and Stereoselective Chemical Editing of Thiostrepton by Rh-Catalyzed Conjugate Arylation: New Analogues and Collateral Enantioselective Synthesis of Amino Acids. J Am Chem Soc 139:15460-15466
Hurtley, Anna E; Stone, Elizabeth A; Metrano, Anthony J et al. (2017) Desymmetrization of Diarylmethylamido Bis(phenols) through Peptide-Catalyzed Bromination: Enantiodivergence as a Consequence of a 2 amu Alteration at an Achiral Residue within the Catalyst. J Org Chem 82:11326-11336
Shugrue, Christopher R; Miller, Scott J (2017) Applications of Nonenzymatic Catalysts to the Alteration of Natural Products. Chem Rev 117:11894-11951
Chinn, Alex J; Kim, Byoungmoo; Kwon, Yongseok et al. (2017) Enantioselective Intermolecular C-O Bond Formation in the Desymmetrization of Diarylmethines Employing a Guanidinylated Peptide-Based Catalyst. J Am Chem Soc 139:18107-18114
Metrano, Anthony J; Abascal, Nadia C; Mercado, Brandon Q et al. (2017) Diversity of Secondary Structure in Catalytic Peptides with ?-Turn-Biased Sequences. J Am Chem Soc 139:492-516
Wadzinski, Tyler J; Gea, Katherine D; Miller, Scott J (2016) A stepwise dechlorination/cross-coupling strategy to diversify the vancomycin 'in-chloride'. Bioorg Med Chem Lett 26:1025-1028
Metrano, A J; Abascal, N C; Mercado, B Q et al. (2016) Structural studies of ?-turn-containing peptide catalysts for atroposelective quinazolinone bromination. Chem Commun (Camb) 52:4816-9
Pelletier, Guillaume; Zwicker, Aaron; Allen, C Liana et al. (2016) Aqueous Glycosylation of Unprotected Sucrose Employing Glycosyl Fluorides in the Presence of Calcium Ion and Trimethylamine. J Am Chem Soc 138:3175-82

Showing the most recent 10 out of 50 publications